Intrasense, French expert in AI-enhanced medical imaging solutions that facilitate diagnosis, decision-making, announces changes to the composition of its Board of Directors.

Intrasense, French expert in AI-enhanced medical imaging solutions that facilitate diagnosis, decision-making, and therapeutic follow-up, publishes its consolidated revenue for the 2025 financial year.

Munich, Germany & Montpellier, France, January 28, 2026 - Abdominal CT is one of the biggest pressure points in radiology. High volumes, long reading lists, and complex oncology follow-up cases make it challenging to ensure both accurate and timely reporting. When subtle liver, bone, or pancreatic findings remain buried in thousands of slices, small oversights can slow entire pathways. Intrasense is addressing this operational reality with DUOnco™, a suite of three standalone AI solutions co-developed with Guerbet that support earlier lesion visibility inside everyday workflows. Intrasense and deepc are partnering to make these solutions available through deepcOS®.

Intrasense, a French expert in medical imaging solutions that facilitate and secure diagnostics, decision-making, and therapeutic follow-up, announces the appointment of Mr. Stephen Armand as Chief Executive Officer of the Company.

Intrasense, French expert in medical imaging solutions to assist diagnosis, decision-making and therapeutic follow-up, confirms its financial targets for the 2025 fiscal year and updates the strategic roadmap presented in March 2025.

Intrasense, French expert in medical imaging solutions to assist and secure diagnosis, decision-making and therapeutic follow-up, announces the publication of its financial calendar for fiscal year 2026.

Intrasense, a French expert in medical imaging solutions facilitating and securing diagnosis, decision-making, and treatment follow-up, announces the publication of its 2025 half-year results and progress on its strategic roadmap. These accounts were approved on September 24, 2025, by the Board of Directors.

Intrasense (ISIN : FR0011179886 – Mnémo : ALINS), a French expert in AI-enhanced medical imaging solutions that facilitate diagnostics, decision-making, and therapeutic follow-up, announces the CE marking under MDR (Medical Device Regulation) for DUOnco™ Pancreas, marking a new milestone in its innovation strategy focused on oncology follow-up.

Intrasense, a French expert in AI-enhanced medical imaging solutions that facilitate and secure diagnosis, decision-making, and therapeutic follow-up, announces its consolidated sales for the first half of fiscal year 2025.

Intrasense (ISIN : FR0011179886 – Mnémo : ALINS), a French expert in AI-enhanced medical imaging solutions that facilitate and secure diagnostics, decision-making, and therapeutic follow-up, provides an update on its activities two months after announcing its strategic roadmap